Royalty Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	30,554	16,564	11,377	12,548	17,514	17,254
Market Cap Growth	65.07%	45.59%	-9.33%	-28.36%	1.51%	-11.18%
Enterprise Value	38,920	27,754	20,459	21,764	25,795	26,699
Last Close Price	53.06	38.64	25.51	28.09	39.52	39.85
PE Ratio	27.87	21.71	13.36	11.10	395.20	26.75
Forward PE	10.16	7.70	6.10	7.47	10.32	13.00
PEG Ratio	0.95	0.79	2.14	2.65	0.94	1.12
PS Ratio	12.52	6.96	5.03	5.33	7.83	7.54
PB Ratio	3.42	2.56	1.64	1.92	3.11	2.99
P/TBV Ratio	4.05	3.37	2.18	2.60	3.08	2.86
P/FCF Ratio	-	6.65	4.11	4.20	8.17	8.55
P/OCF Ratio	11.70	6.65	4.11	4.20	8.17	8.55
EV/Sales Ratio	15.95	11.67	9.04	9.24	11.53	11.66
EV/EBITDA Ratio	-	17.75	15.83	14.59	84.00	18.66
EV/EBIT Ratio	23.48	17.80	15.83	14.59	84.00	18.66
EV/FCF Ratio	-	11.15	7.39	7.28	12.03	13.23
Debt / Equity Ratio	0.86	0.88	0.64	0.61	0.64	0.69
Debt / EBITDA Ratio	5.64	5.73	5.89	4.11	23.18	4.96
Debt / FCF Ratio	3.43	3.60	2.75	2.05	3.32	3.52
Net Debt / Equity Ratio	1.22	1.29	0.96	0.87	0.96	0.86
Net Debt / EBITDA Ratio	5.27	5.33	5.17	3.79	17.52	3.48
Net Debt / FCF Ratio	3.20	3.35	2.41	1.89	2.51	2.47
Asset Turnover	0.12	0.13	0.13	0.14	0.13	0.14
Quick Ratio	1.15	1.02	0.76	3.09	1.52	12.80
Current Ratio	2.66	2.40	1.44	7.90	2.19	16.81
Return on Equity (ROE)	13.83%	13.20%	13.03%	17.34%	2.33%	12.32%
Return on Assets (ROA)	8.06%	8.24%	7.47%	8.99%	1.79%	8.53%
Return on Invested Capital (ROIC)	8.32%	8.60%	7.79%	9.64%	2.02%	9.73%
Return on Capital Employed (ROCE)	8.30%	8.68%	7.79%	9.36%	1.86%	8.66%
Earnings Yield	2.70%	4.61%	7.49%	9.01%	0.25%	3.74%
FCF Yield	-	15.03%	24.34%	23.81%	12.24%	11.69%
Dividend Yield	1.77%	2.28%	3.29%	2.85%	1.93%	1.73%
Payout Ratio	47.79%	49.06%	43.83%	31.58%	778.21%	46.02%
Buyback Yield / Dilution	5.11%	4.99%	1.46%	-37.66%	-5.59%	43.84%
Total Shareholder Return	6.88%	7.27%	4.75%	-34.81%	-3.66%	45.57%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q